Global Rank
Last scanned
Domain Age
Daily Visitors
Updated:
SMA Gene Therapy | ZOLGENSMA® Page
Learn how ZOLGENSMA® is the only one-time gene therapy for spinal muscular atrophy. See Safety and Full Prescribing Information. For US audiences only.
This website is hosted with CloudFlare, Inc., which reserves the following IP addresses for zolgensma.com: 104.18.36.122, 172.64.151.134. Moreover, DNS used with this website include a1-254.akam.net, a2-66.akam.net, a24-65.akam.net, a28-67.akam.net, a7-64.akam.net, a9-65.akam.net, dns1.novartis.com, dns2.novartis.com, dns3.novartis.com, dns4.novartis.com. Subnet identifier ranges from 104.16.0.0 to 104.31.255.255. Classless Inter-Domain Routing (CIDR) is 104.16.0.0/12. ARIN net type is Direct Allocation.
Global Rank
Last scanned
Domain Age
Daily Visitors
CloudFlare, Inc.
a1-254.akam.net
a2-66.akam.net
a24-65.akam.net
a28-67.akam.net
a7-64.akam.net
a9-65.akam.net
dns1.novartis.com
dns2.novartis.com
dns3.novartis.com
dns4.novartis.com
{{value}}
2017-09-01
2027-08-31
MarkMonitor Inc.
{{value}}
The registrar of zolgensma.com is MarkMonitor Inc. and the name expires on 2027-08-31. According to open source data, you can reach the owner at novartis.domains@markmonitor.com but please make sure you have a good reason for unsolicited messages. Their country of residence is Switzerland, Swiss Confederation.
Dec 31, 2019
Jan 21, 2021
N/A
801
N/A
N/A
N/A
534
675.1K
1K
N/A
N/A
N/A
N/A